Examining the joint effect of two functional variants in two dopamine-related genes (DRD3 and COMT) on ADHD-relevant behaviors under three experimental conditions (EC).
Method:
362 children with ADHD were assessed by parents and teachers during a week of baseline evaluation, followed by 1 week of MPH and placebo, administered in a double-blind crossover design.
Results:
Statistically significant 3-way (DRD3-by-COMT-by-EC; p = .004) and 2-way interactions (COMT by EC; p = .002) were observed on Conners’-Teachers scores. Children with the COMT Met/Met genotype had lower scores at baseline and on placebo compared to the other genotype groups. Furthermore, stratifying the children according to their COMT genotypes helped to detect statistically significant and biologically meaningful effects of DRD3 genotype.
Conclusions:
These findings suggest that COMT and DRD3 genetic variants may together play a role in ADHD symptomatology and response to treatment through gene-gene interaction.
ArnstenA. F. (2009). Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: An important role for prefrontal cortex dysfunction. CNS Drugs, 23(Suppl. 1), 33–41.
2.
BarkleyR. A. (2010). Differential diagnosis of adults with ADHD: The role of executive function and self-regulation. Journal of Clinical Psychiatry, 71(7), e17.
3.
ButtonK. S.IoannidisJ. P.MokryszC.NosekB. A.FlintJ.RobinsonE. S.MunafòM. R. (2013). Power failure: Why small sample size undermines the reliability of neuroscience. Nature Reviews Neuroscience, 14(5), 365–376.
4.
ChenJ.LipskaB. K.HalimN.MaQ. D.MatsumotoM.MelhemS.KolachanaB. S.HydeT. M.HermanM. M.ApudJ.EganM. F.KleinmanJ. E.WeinbergerD. R. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics, 75(5), 807–821.
5.
de la Fuente-FernandezR.LidstoneS.StoesslA. J. (2006). Placebo effect and dopamine release. Journal of Neural Transmission Supplementum, 70, 415–418.
6.
de la Fuente-FernandezR.RuthT. J.SossiV.SchulzerM.CalneD. B.StoesslA. J. (2001). Expectation and dopamine release: Mechanism of the placebo effect in Parkinson’s disease. Science, 293(5532), 1164–1166.
7.
DemontisD.WaltersR. K.MartinJ.MattheisenM.AlsT. D.AgerboE., et al. (2019). Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics, 51(1), 63–75.
8.
FageeraW.SenguptaS. M.LabbeA.GrizenkoN.JooberR. (2018). DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study. Neuromolecular Medicine, 20(4), 515–524.
9.
FaraoneS. V.MickE. (2010). Molecular genetics of attention deficit hyperactivity disorder. Psychiatric Clinics of North America33(1), 159–180.
10.
FreitagC. M.RohdeL. A.LemppT.RomanosM. (2010). Phenotypic and measurement influences on heritability estimates in childhood ADHD. European Child & Adolescent Psychiatry, 19(3), 311–323.
11.
GirardS. L.DionP. A.BourassaC. V.GeoffroyS.Lachance-TouchetteP.BarhdadiA.LangloisM.JooberR.KrebsM. O.DubeM. P.RouleauG. A. (2015). Mutation burden of rare variants in schizophrenia candidate genes. PLoS One, 10(6), e0128988.
HawiZ.CumminsT. D.TongJ.JohnsonB.LauR.SamarraiW.BellgroveM. A. (2015). The molecular genetic architecture of attention deficit hyperactivity disorder. Molecular Psychiatry, 20(3), 289–297.
14.
HellstrandM.DanielsenE. A.SteenV. M.EkmanA.ErikssonE.NilssonC. L. (2004). The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. Journal of Medical Genetics, 41(11), 867–871.
15.
HinneyA.ScheragA.JarickI.AlbayrakO.PutterC.PechlivanisS., et al. (2011). Genome-wide association study in German patients with attention deficit/hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 156(8), 888–897.
16.
LannfeltL.SokoloffP.MartresM. P.PilonCGirosB.JönssonE.SedvallG.SchwartzJ. -C. (1992). Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatric Genetics, 2(4), 249–256.
17.
Le RouzicA.Alvarez-CastroJ. M.CarlborgO. (2008). Dissection of the genetic architecture of body weight in chicken reveals the impact of epistasis on domestication traits. Genetics, 179(3), 1591–1599.
18.
Le RouzicA.CarlborgO. (2008). Evolutionary potential of hidden genetic variation. Trends in Ecology & Evolution, 23(1), 33–37.
19.
LottaT.VidgrenJ.TilgmannC.UlmanenI.MelenK.JulkunenI.TaskinenJ. (1995). Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry, 34(13), 4202–4210.
20.
LundstromK.TurpinM. P. (1996).Proposed schizophrenia-related gene polymorphism: Expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochemical and Biophysical Research Communications, 225(3), 1068–1072.
21.
LundstromK.TurpinM. P.LargeC.RobertsonG.ThomasP.LewellX. Q. (1998). Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus system. Journal of Receptors and Signal Transduction, 18(2–3), 133–150.
22.
MartinN.ScourfieldJ.McGuffinP.(2002). Observer effects and heritability of childhood attention-deficit hyperactivity disorder symptoms. British Journal of Psychiatry, 180(3), 260–265.
23.
MartinezL.PradaE.SatlerC.TavaresM. C.TomazC. (2016). Executive dysfunctions: The role in attention deficit hyperactivity and post-traumatic stress neuropsychiatric disorders. Frontiers in Psychology, 7, 1230.
24.
MickE.TodorovA.SmalleyS.HuX.LooS.ToddR. D.BiedermanJ.ByrneD.DechairoB.GuineyA.McCrackenJ.McGoughJ.NelsonS. F.ReiersenA.M.WilensT.E.WozniakJ.NealeB. M.FaraoneS. V. (2010). Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49(9), 898–905.e3.
25.
NealeB. M.Lasky-SuJ.AnneyR.FrankeB.ZhouK.MallerJ. B., et al. (2008). Genome-wide association scan of attention deficit hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B(8), 1337–1344.
26.
NealeB. M.MedlandS.RipkeS.AnneyR. J.AshersonP.BuitelaarJ., et al. (2010). Case-control genome-wide association study of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 49(9), 906–920.
PoldermanT.J.BenyaminB.de LeeuwC. ASullivanP. F.van BochovenA.VisscherP. M.PosthumaD. (2015). Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nature Genetics, 47(7), 702–709.
29.
RowlandA. S.UmbachD. M.StalloneL.NaftelA. J.BohligE. M.SandlerD. P. (2002). Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. American Journal of Public Health, 92(2), 231–234.
30.
ShermanD. K.McGueM. K.IaconoW. G. (1997). Twin concordance for attention deficit hyperactivity disorder: A comparison of teachers’ and mothers’ reports. American Journal of Psychiatry, 154(4), 532–535.
31.
StergiakouliE.HamshereM.HolmansP.LangleyK.ZaharievaI.HawiZ.KentL.GillM.WilliamsN.OwenM. J.O’DonovanM.ThaparA.; deCODE Genetics; & Psychiatric GWAS Consortium: ADHD Subgroup. (2012). Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. American Journal of Psychiatry, 169(2), 186–194.
32.
ThaparA.LangleyK.O’DonovanM.OwenM. (2006). Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies. Molecular Psychiatry, 11(8), 714–720.
33.
TunbridgeE. M.BannermanD. M.SharpT.HarrisonP. J. (2004). Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. Journal of Neuroscience, 24(23), 5331–5335.
34.
WilensT. E. (2008). Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 28(3 Suppl. 2), S46–S53.
35.
WillcuttE. G. (2012).The prevalence of DSM-IV attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics, 9(3), 490–499.
36.
WillcuttE. G.DoyleA. E.NiggJ. T.FaraoneS. V.PenningtonB. F. (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review. Biological Psychiatry, 57(11), 1336–1346.
37.
WilliamsN. M.FrankeB.MickE.AnneyR. J.FreitagC. M.GillM., et al. (2012). Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: The role of rare variants and duplications at 15q13.3. American Journal of Psychiatry, 169(2), 195–204.
38.
WiseR. A.BozarthM. A. (1984). Brain reward circuitry: four circuit elements “wired” in apparent series. Brain Research Bulletin, 12(2), 203–208.
39.
YangL.NealeB. M.LiuL.LeeS. H.WrayN. R.JiN.LiH.QianQ.WangD.LiJ.FaraoneS. V.WangY.; & Psychiatric GWAS Consortium: ADHD Subgroup. (2013). Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: Genome-wide association study of both common and rare variants. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162(5), 419–430.
40.
ZayatsT.AthanasiuL.SonderbyI.DjurovicS.WestlyeL. TTamnesC. K.FladbyT.AaseH.ZeinerP.Reichborn-KjennerudT.KnappskogP. M.KnudsenG. P.AndreassenO. A.JohanssonS.HaavikJ. (2015). Genome-wide analysis of attention deficit hyperactivity disorder in Norway. PloS One, 10(4), e0122501.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
